Medicenna Therapeutics Corp (TSX:MDNA)
C$ 2.4 0.03 (1.27%) Market Cap: 183.44 Mil Enterprise Value: 147.81 Mil PE Ratio: 0 PB Ratio: 8.02 GF Score: 42/100

Q4 2021 Medicenna Therapeutics Corp Earnings Call Transcript

May 28, 2021 / 12:30PM GMT
Release Date Price: C$4.7 (-0.42%)
Operator

Hello, and welcome to Medicenna Therapeutics Fiscal Year 2021 Earnings Call. (Operator Instructions). Please be advised this call is being recorded at the company's request. I would now like to turn the call over to Dan Ferry of Lifesci Advisors. Please go ahead.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator, and thank you all for participating in today's conference call. Earlier today, Medicenna issued a press release providing financial results and corporate updates for the fiscal year ended March 31, 2021. If you have not seen the press release, it is available on the Investors page of Medicenna's website.

Before we begin, I would like to remind you that certain statements and information shared during this call constitute forward-looking information within the meaning of applicable securities laws and relate to the future operations of the company and other statements that are not historical facts, including statements related to the clinical potential and development of the MDNA11, MDNA55 and BiSKITs

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot